U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H4O3
Molecular Weight 112.0835
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-Furoic acid

SMILES

OC(=O)C1=CC=CO1

InChI

InChIKey=SMNDYUVBFMFKNZ-UHFFFAOYSA-N
InChI=1S/C5H4O3/c6-5(7)4-2-1-3-8-4/h1-3H,(H,6,7)

HIDE SMILES / InChI

Molecular Formula C5H4O3
Molecular Weight 112.0835
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Survey of antibiotic resistance in an integrated marine aquaculture system under oxolinic acid treatment.
2006-03
Genotoxic potential of quinolone antimicrobials in the in vitro comet assay and micronucleus test.
2006-02-28
Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(IV), oxovanadium(V) and mu-bis(oxo)bis{oxovanadium(V)} complexes.
2006-02-21
A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis.
2006-02
Determination of fluoroquinolones in chicken tissues by LC-coupled electrospray ionisation and atmospheric pressure chemical ionisation.
2006-01
Validation of a novel HPLC sorbent material for the determination of ten quinolones in human and veterinary pharmaceutical formulations.
2005-12
Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo.
2005-12
Study on the interaction between nucleic acid and Eu3+-oxolinic acid and the determination of nucleic acid using the resonance light scattering technique.
2005-12
Efficient synthesis of furan-2-ylacetates, 7-(alkoxycarbonyl)benzofurans, and 7-(alkoxycarbonyl)-2,3-dihydrobenzofurans based on cyclization reactions of free and masked dianions: a "cyclization/dehydrogenation" strategy.
2005-11-25
Browning of model orange juice solution: factors affecting the formation of decomposition products.
2005-11
Solid state characterization of mometasone furoate anhydrous and monohydrate forms.
2005-11
Isolation and molecular characterization of quinolone resistant Salmonella spp. from poultry farms.
2005-10-31
Antibiotic resistance in bacteria from shrimp farming in mangrove areas.
2005-10-15
Multiresidue method for simultaneous determination of ten quinolone antibacterial residues in multimatrix/multispecies animal tissues by liquid chromatography with fluorescence detection: single laboratory validation study.
2005-09-15
Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis.
2005-09
Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
2005-07
Standardization of a broth microdilution susceptibility testing method to determine minimum inhibitory concentrations of aquatic bacteria.
2005-05-20
Vibrational spectroscopic characterization of fluoroquinolones.
2005-05
Identification of molecular target of AMP-activated protein kinase activator by affinity purification and mass spectrometry.
2005-04-01
Study of the evolution and degradation products of ciprofloxacin and oxolinic acid in river water samples by HPLC-UV/MS/MS-MS.
2005-03
Identification of nonpeptidic small-molecule inhibitors of interleukin-2.
2005-02-15
Synthesis, characterisation and catalytic potential of hydrazonato-vanadium(V) model complexes with [VO]3+ and [VO2]+ cores.
2005-02-07
Tailored cellulose esters: synthesis and structure determination.
2005-01-11
[Determination of furoic acid and furfuryl alcohol by reversed-phase high performance liquid chromatography].
2005-01
Micellar electrokinetic chromatography for determination of drug partition in phospholipids.
2005-01
Nasal allergies and beyond: a clinical review of the pharmacology, efficacy, and safety of mometasone furoate.
2005
Spectroscopic properties of various quinolone antibiotics in aqueous-organic solvent mixtures.
2004-12-30
Determination and on-line clean-up of (fluoro)quinolones in bovine milk using column-switching liquid chromatography fluorescence detection.
2004-12-24
Residues of selected antibiotics in water and mud from shrimp ponds in mangrove areas in Viet Nam.
2004-12
Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate.
2004-11-01
Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review.
2004-10-27
Multi-maleimides bearing electron-donating chromophores: reversible fluorescence and aggregation behavior.
2004-10-06
Structures of the Escherichia coli PutA proline dehydrogenase domain in complex with competitive inhibitors.
2004-10-05
Stability of fluoroquinolone antibiotics in river water samples and in octadecyl silica solid-phase extraction cartridges.
2004-09
Mechanisms of quinolone resistance and clonal relationship among Aeromonas salmonicida strains isolated from reared fish with furunculosis.
2004-09
Potential drug (oxytetracycline and oxolinic acid) pollution from Mediterranean sparid fish farms.
2004-08-25
Significant receptor affinities of metabolites and a degradation product of mometasone furoate.
2004-07-22
Characterization of degradation products of mometasone furoate.
2004-05
Human receptor kinetics, tissue binding affinity, and stability of mometasone furoate.
2004-05
The bryophyte Fontinalis antipyretica Hedw. bioaccumulates oxytetracycline, flumequine and oxolinic acid in the freshwater environment.
2004-04-25
Enantiodivergent preparation of optically active oxindoles having a stereogenic quaternary carbon center at the C3 position via the lipase-catalyzed desymmetrization protocol: effective use of 2-furoates for either enzymatic esterification or hydrolysis.
2004-04-02
Stability studies on diloxanide furoate: effect of pH, temperature, gastric and intestinal fluids.
2004-04
Browning and decomposed products of model orange juice.
2004-03
Experimental study on the bioaccumulation of oxytetracycline and oxolinic acid by the blue mussel (Mytilus edulis). An evaluation of its ability to bio-monitor antibiotics in the marine environment.
2004-03
Antimicrobial susceptibility of Salmonella isolated from cattle, swine and poultry (2001-2002): report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program.
2004-02
[Spectra of complexes Eu(III)-furoic acid].
2004-01
[Development of novel asymmetric reactions oriented to next-generation enzymatic organic syntheses].
2003-11
A new antioxidant isobenzofuranone derivative from the algicolous marine fungus Epicoccum sp.
2003-09
Features of mometasone furoate nasal spray and its utility in the management of allergic rhinitis.
2003-09
[Determination of oxolinic acid residues in baked and fresh eels by high performance liquid chromatography without derivatization].
2002-09
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:16:11 GMT 2025
Edited
by admin
on Mon Mar 31 18:16:11 GMT 2025
Record UNII
P577F6494A
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2-Furoic acid
MI  
Systematic Name English
NSC-58965
Preferred Name English
NSC-8842
Code English
2-FUROIC ACID [MI]
Common Name English
.ALPHA.-FUROIC ACID
Common Name English
2-FURANOIC ACID
Systematic Name English
PYROMUCIC ACID
Common Name English
2-CARBOXYFURAN
Systematic Name English
2-FURANCARBOXYLIC ACID
Systematic Name English
2-FUROIC ACID [USP IMPURITY]
Common Name English
.ALPHA.-FURANCARBOXYLIC ACID
Common Name English
Classification Tree Code System Code
EPA PESTICIDE CODE 643301
Created by admin on Mon Mar 31 18:16:11 GMT 2025 , Edited by admin on Mon Mar 31 18:16:11 GMT 2025
Code System Code Type Description
CAS
88-14-2
Created by admin on Mon Mar 31 18:16:11 GMT 2025 , Edited by admin on Mon Mar 31 18:16:11 GMT 2025
PRIMARY
NSC
8842
Created by admin on Mon Mar 31 18:16:11 GMT 2025 , Edited by admin on Mon Mar 31 18:16:11 GMT 2025
PRIMARY
FDA UNII
P577F6494A
Created by admin on Mon Mar 31 18:16:11 GMT 2025 , Edited by admin on Mon Mar 31 18:16:11 GMT 2025
PRIMARY
ECHA (EC/EINECS)
201-803-0
Created by admin on Mon Mar 31 18:16:11 GMT 2025 , Edited by admin on Mon Mar 31 18:16:11 GMT 2025
PRIMARY
CHEBI
30845
Created by admin on Mon Mar 31 18:16:11 GMT 2025 , Edited by admin on Mon Mar 31 18:16:11 GMT 2025
PRIMARY
PUBCHEM
6919
Created by admin on Mon Mar 31 18:16:11 GMT 2025 , Edited by admin on Mon Mar 31 18:16:11 GMT 2025
PRIMARY
MERCK INDEX
m5606
Created by admin on Mon Mar 31 18:16:11 GMT 2025 , Edited by admin on Mon Mar 31 18:16:11 GMT 2025
PRIMARY Merck Index
WIKIPEDIA
2-FUROIC ACID
Created by admin on Mon Mar 31 18:16:11 GMT 2025 , Edited by admin on Mon Mar 31 18:16:11 GMT 2025
PRIMARY
NSC
58965
Created by admin on Mon Mar 31 18:16:11 GMT 2025 , Edited by admin on Mon Mar 31 18:16:11 GMT 2025
PRIMARY
EPA CompTox
DTXSID6041420
Created by admin on Mon Mar 31 18:16:11 GMT 2025 , Edited by admin on Mon Mar 31 18:16:11 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP